Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Sphere Fluidics — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Sphere Fluidics rebrands to Sphere Bio to expand market focus and growth potential

Feb 27, 2025•about 1 year ago

Contract Type

partnership

CambridgeBiotechnologySoftwareScience And Engineering

Description

Sphere Fluidics, now known as Sphere Bio, has rebranded to reflect its transition from a leading droplet-based microfluidics innovator to an established commercial provider of life sciences tools and solutions. The rebrand signifies expanded market focus and growth potential in impactful and emerging research areas based on the company's proven track record.

Company Information

Company

Sphere Fluidics

Location

Cambridge, England, United Kingdom

About

The platform can process millions of samples per day, assessing and isolating rare or valuable cell variants or biological products, to simplify and improve throughput across antibody discovery, cell line development and single cell diagnostics. Sphere Fluidics will use the funding to enable the expansion of the Company’s international sales activities in key markets and improving its support for customers.

Predictive Intelligence
Strategic

ML-powered predictions for Sphere Fluidics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months